What is Baijin Life Science Holdings Enterprise Value?
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Baijin Life Science Holdings Enterprise Value Chart
Competitive Comparison of Baijin Life Science Holdings's Enterprise Value
For the Luxury Goods subindustry, Baijin Life Science Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings's Enterprise Value Distribution in the Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's Enterprise Value falls into.
Baijin Life Science Holdings Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings (HKSE:01466) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Baijin Life Science Holdings's EV-to-EBIT for today is
Baijin Life Science Holdings's current Enterprise Value is HK$508.79 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was HK$-4.63 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Baijin Life Science Holdings's EV-to-EBITDA for today is:
Baijin Life Science Holdings's current Enterprise Value is HK$508.79 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.42 Mil.
Baijin Life Science Holdings's current Enterprise Value is HK$508.79 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was HK$99.46 Mil.
Baijin Life Science Holdings's current Enterprise Value is HK$508.79 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was HK$-14.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings Enterprise Value Related Terms
Thank you for viewing the detailed overview of Baijin Life Science Holdings's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01466 has been successfully added to your 